Ruxolitinib Impurity 45 | CAS 3035548-80-9 - Request Quote
Ruxolitinib Impurity 45
| SZ CAT No: | SZ-R044073 |
| CAS No | 3035548-80-9 |
| Mol.F. | C8H15N3 |
| Mol.Wt. | 153.2 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Ruxolitinib Impurity 45 is chemically (R)-5-Cyclopentyl-4,5-dihydro-1H-pyrazol-3-amine. Ruxolitinib Impurity 45 is supplied with detailed characterization data compliant with regulatory guideline. Ruxolitinib Impurity 45 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Ruxolitinib.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 3035548-80-9
Purchase 3035548-80-9
Order 3035548-80-9
Enquire 3035548-80-9
price of 3035548-80-9
3035548-80-9 Supplier
3035548-80-9 Manufacturer
3035548-80-9 Exporter
buy high quality Ruxolitinib Impurity 45
Purchase Ruxolitinib Impurity 45
Ruxolitinib Impurity 45 suppliers
Ruxolitinib Impurity 45 manufacturers
Ruxolitinib Impurity 45 price
Order Ruxolitinib Impurity 45
Enquire Ruxolitinib Impurity 45
Ruxolitinib Impurity 45 cost
Ruxolitinib Impurity 45 Supplier
Ruxolitinib Impurity 45 Distributor
Ruxolitinib Impurity 45 for Method Validation
Ruxolitinib Reference Standard
Ruxolitinib Impurity 45 for ANDA Filing
Ruxolitinib Impurity 45 for Forced Degradation Studies
Ruxolitinib Impurity 45 Identification Standards
Ruxolitinib Impurity 45 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.